These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15368992)

  • 21. Parametric two-stage sequential quality assurance test of dose content uniformity.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(1):143-57. PubMed ID: 17219760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptance Probability (P a) Analysis for Process Validation Lifecycle Stages.
    Alsmeyer D; Pazhayattil A; Chen S; Munaretto F; Hye M; Sanghvi P
    AAPS PharmSciTech; 2016 Apr; 17(2):516-22. PubMed ID: 26024723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the US.
    Fisher AC; Viehmann A; Ashtiani M; Friedman RL; Buhse L; Kopcha M; Woodcock J
    JAMA Netw Open; 2020 Aug; 3(8):e2013920. PubMed ID: 32833019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The compliance and science of Blend Uniformity Analysis.
    Berman J
    PDA J Pharm Sci Technol; 2001; 55(4):209-22. PubMed ID: 11505553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delegations of authority and organization; Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1993 Apr; 58(61):17093-4. PubMed ID: 10125229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Content uniformity testing for stratified samples via parametric tolerance interval testing.
    Novick S; Hudson-Curtis B
    J Biopharm Stat; 2018; 28(3):463-474. PubMed ID: 28422566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity.
    El-Hagrasy AS; Morris HR; D'Amico F; Lodder RA; Drennen JK
    J Pharm Sci; 2001 Sep; 90(9):1298-307. PubMed ID: 11745782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolution test acceptance sampling plans.
    Tsong Y; Hammerstrom T; Lin K; Ong TE
    J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Shen M; Lostritto RT; Poochikian GK
    J Biopharm Stat; 2008; 18(5):976-84. PubMed ID: 18781529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: USP content uniformity test.
    Madan PL
    J Pharm Sci; 1976 Jan; 65(1):VIII. PubMed ID: 1255410
    [No Abstract]   [Full Text] [Related]  

  • 32. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 6 on Uniformity of Dosage Units General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Jun; 79(115):34314-5. PubMed ID: 25011159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blend uniformity end-point determination using near-infrared spectroscopy and multivariate calibration.
    Sulub Y; Konigsberger M; Cheney J
    J Pharm Biomed Anal; 2011 Jun; 55(3):429-34. PubMed ID: 21398064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real time monitoring of powder blend bulk density for coupled feed-forward/feed-back control of a continuous direct compaction tablet manufacturing process.
    Singh R; Román-Ospino AD; Romañach RJ; Ierapetritou M; Ramachandran R
    Int J Pharm; 2015 Nov; 495(1):612-625. PubMed ID: 26386140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Registration of similar biological products--Singapore's approach.
    Poh J; Tam KT
    Biologicals; 2011 Sep; 39(5):343-5. PubMed ID: 21783381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unit dose sampling and final product performance: an alternative approach.
    Geoffroy JM; Leblond D; Poska R; Brinker D; Hsu A
    Drug Dev Ind Pharm; 2001 Aug; 27(7):731-43. PubMed ID: 11694021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Jan; 80(17):4282-3. PubMed ID: 25730921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line monitoring of blend uniformity in continuous drug product manufacturing process--The impact of powder flow rate and the choice of spectrometer: Dispersive vs. FT.
    Shi Z; McGhehey KC; Leavesley IM; Manley LF
    J Pharm Biomed Anal; 2016 Jan; 118():259-266. PubMed ID: 26580823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer.
    Kornchankul W; Hamed E; Parikh NH; Sakr A
    Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.